Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo (Q33755168)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo |
scientific article |
Statements
1 reference
Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo (English)
1 reference
Masanori Daibata
1 reference
Kentaro Bandobashi
1 reference
Masayuki Kuroda
1 reference
Shosuke Imai
1 reference
Isao Miyoshi
1 reference
Hirokuni Taguchi
1 reference
1 May 2005
1 reference
1 reference
79
1 reference
5875-5879
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference